Michaela Orlitová

Michaela Orlitová

Auto-generated profile, based on publicly available information

Michaela Orlitová

Department of Cardiovascular sciences, KU Leuven, Leuven, Belgium

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2022 in Cells
Verified
Journal Article
Open access
PDF file
JSJan Van Slambrouck
Jan Van Slambrouck
DRDirk Van Raemdonck
Dirk Van Raemdonck
RVRobin Vos
Robin Vos
CVCedric Vanluyten
Cedric Vanluyten
AVArno Vanstapel
Arno Vanstapel
LCLaurens J Ceulemans
Laurens J Ceulemans
Primary graft dysfunction (PGD) is the clinical syndrome of acute lung injury after lung transplantation (LTx). However, PGD is an umbrella term that encompasses the ongoing pathophysiological and -biological mechanisms occurring in the lung grafts. Therefore, we aim to provide a focused review on the clinical, physiological, radiological, histological and cellular level of PGD. PGD is graded based on hypoxemia and chest X-ray (CXR) infiltrates. High-grade PGD is associated with inferior outcome after LTx. Lung edema is the main characteristic of PGD and alters pulmonary compliance, gas exchange and circulation. A conventional CXR provides a rough estimate of lung edema, while a chest computed tomography (CT) results in a more in-depth analysis. Macroscopically, interstitial and alveolar edema can be distinguished below the visceral lung surface. On the histological level, PGD correlates to a pattern of diffuse alveolar damage (DAD). At the cellular level, ischemia-reperfusion injury (IRI) is the main trigger for the disruption of the endothelial-epithelial alveolar barrier and inflammatory cascade. The multilevel approach integrating all PGD-related aspects results in a better understanding of acute lung failure after LTx, providing novel insights for future therapies.

1 November 2023 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Open access
MOMichaela Orlitová
Michaela Orlitová
TVTom Verbelen
Tom Verbelen
AFAnna E. Frick
Anna E. Frick
AVArno Vanstapel
Arno Vanstapel
DBDieter Van Beersel
Dieter Van Beersel
ANArne P. Neyrinck
Arne P. Neyrinck
In contrast to the abundant literature of mechanical pulmonary artery clamping to increase right ventricular afterload, we developed a model adding a biological factor of pulmonary ischemia-reperfusion injury. We did not only focus on the right ventricular behavior, but also on the interaction with the injured lung. We are the first to describe this interaction while addressing the hemodynamic intraoperative phases of clinical lung transplantation.

2 September 2024 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
JSJan Van Slambrouck
Jan Van Slambrouck
HDHerbert Decaluwé
Herbert Decaluwé
CVCedric Vanluyten
Cedric Vanluyten
CVChristelle M Vandervelde
Christelle M Vandervelde
MOMichaela Orlitová
Michaela Orlitová
LCLaurens J Ceulemans
Laurens J Ceulemans
Historically, the perfusion-guided sequence suggests to first transplant the side with lowest lung perfusion. This sequence is thought to limit right ventricular afterload and prevent acute heart failure after first pneumonectomy. As a paradigm shift, we adopted the right-first implantation sequence, irrespective of lung perfusion. The right donor lung generally accommodates a larger proportion of the cardiac output. We hypothesized that the right-first sequence reduces the likelihood of oedema formation in the firstly transplanted graft during second-lung implantation. Our objective was to compare the perfusion-guided and right-first sequence for intraoperative extracorporeal membrane oxygenation (ECMO) need and primary graft dysfunction (PGD). A retrospective single-center cohort study (2008–2021) including double-lung transplant cases (N = 696) started without ECMO was performed. Primary end-points were intraoperative ECMO cannulation and PGD grade 3 (PGD3) at 72 h. Secondary end-points were patient and chronic lung allograft dysfunction (CLAD)-free survival. In cases with native left lung perfusion ≤50% propensity score adjusted comparison of the perfusion-guided and right-first sequence was performed. When left lung perfusion was ≤50%, right-first implantation was done in 219 and left-first in 189 cases. Intraoperative escalation to ECMO support was observed in 10.96% of right-first vs 19.05% of left-first cases (odds ratio 0.448; 95% confidence interval 0.229–0.0.878; p = 0.0193). PGD3 at 72 h was observed in 8.02% of right-first vs 15.64% of left-first cases (0.566; 0.263–1.217; p = 0.1452). Right-first implantation did not affect patient or CLAD-free survival. The right-first implantation sequence in off-pump double-lung transplantation reduces need for intraoperative ECMO cannulation with a trend towards less PGD grade 3.

23 September 2022 in American Journal of Transplantation
Verified
Journal Article
Open access
MOMichaela Orlitová
Michaela Orlitová
MGMarc Gewillig
Marc Gewillig
JSJan Van Slambrouck
Jan Van Slambrouck
DVDirk Vlasselaers
Dirk Vlasselaers
BJBart Jacobs
Bart Jacobs
LCLaurens J Ceulemans
Laurens J Ceulemans
Pulmonary vein stenosis (PVS) and pulmonary vein occlusion (PVO) represent rare complications after lung transplantation (LTx), with limited therapeutic options and a high risk of graft loss. We present 2 cases of successful endovascular transatrial stenting following double LTx. A 60-year-old woman with chronic obstructive pulmonary disease who underwent double lobar LTx was diagnosed at postoperative day 72 with a high-grade PVS on the left side. A 22-year-old woman with idiopathic pulmonary arterial hypertension who underwent double LTx was diagnosed 9 days later with PVO of the left upper lobe vein. To avoid surgical reintervention, endovascular transatrial dilatation and stenting were performed successfully in both cases. Transatrial endovascular stenting of PVS or PVO after LTx seems an effective and safe treatment option that should be considered for these life-threatening complications and executed with care.

22 February 2024 in EBioMedicine
Verified
Journal Article
Open access
PKPieterjan Kerckhof
Pieterjan Kerckhof
GAGene P.L. Ambrocio
Gene P.L. Ambrocio
HBHanne Beeckmans
Hanne Beeckmans
JKJanne Kaes
Janne Kaes
VGVincent Geudens
Vincent Geudens
RVRobin Vos
Robin Vos
Chronic lung allograft dysfunction (CLAD) encompasses three main phenotypes: bronchiolitis obliterans syndrome (BOS), restrictive allograft syndrome (RAS) and a Mixed phenotype combining both pathologies. How the airway structure in its entirety is affected in these phenotypes is still poorly understood. A detailed analysis of airway morphometry was applied to gain insights on the effects of airway remodelling on the distribution of alveolar ventilation in end-stage CLAD. Ex vivo whole lung μCT and tissue-core μCT scanning of six control, six BOS, three RAS and three Mixed explant lung grafts (9 male, 9 female, 2014-2021, Leuven, Belgium) were used for digital airway reconstruction and calculation of airway dimensions in relation to luminal obstructions. BOS and Mixed explants demonstrated airway obstructions of proximal bronchioles (starting at generation five), while RAS explants particularly had airway obstructions in the most distal bronchioles (generation >12). In BOS and Mixed explants 76% and 84% of bronchioles were obstructed, respectively, while this was 22% in RAS. Bronchiolar obstructions were mainly caused by lymphocytic inflammation of the airway wall or fibrotic remodelling, i.e. constrictive bronchiolitis. Proximal bronchiolectasis and imbalance in distal lung ventilation were present in all CLAD phenotypes and explain poor lung function and deterioration of specific lung function parameters. Alterations in the structure of conducting bronchioles revealed CLAD to affect alveolar ventilatory distribution in a regional fashion. The significance of various obstructions, particularly those associated with mucus, is highlighted. This research was funded with the National research fund Flanders (G060322N), received by R.V.

15 June 2025 in JHLT Open
Verified
Journal Article
Open access
MOMichaela Orlitová
Michaela Orlitová
BDBert Demeulenaere
Bert Demeulenaere
DBDieter Van Beersel
Dieter Van Beersel
DRDirk E. Van Raemdonck
Dirk E. Van Raemdonck
RVRobin Vos
Robin Vos
ANArne P. Neyrinck
Arne P. Neyrinck
Extracorporeal life support (ECLS) serves as a bridge to lung transplantation (BTT) for patients with acute respiratory failure (ARF) or right ventricular (RV) dysfunction/failure (RVD/RVF). Proper assessment and management of RV function in BTT patients are crucial for successful outcomes. However, there is a lack of consensus on standardized RV assessment strategies or optimal ECLS configurations. We aim to synthesize current evidence on RVD/RVF assessment and management in BTT patients requiring ECLS, providing a foundation to aid development of standardized clinical algorithms.